XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.
about
Inhibition of exportin-1 function results in rapid cell cycle-associated DNA damage in cancer cells.A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy.Dexrazoxane Averts Idarubicin-Evoked Genomic Damage by Regulating Gene Expression Profiling Associated With the DNA Damage-Signaling Pathway in BALB/c Mice.A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.Karyopherins in cancer.Clinical Dosing Regimen of Selinexor Maintains Normal Immune Homeostasis and T-cell Effector Function in Mice: Implications for Combination with Immunotherapy.Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberineNuclear transport inhibition in acute myeloid leukemia: recent advances and future perspectivesAnti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
P2860
Q38806892-06139DCB-19F1-4C1F-9DB8-7D44A8DB3B0BQ38881093-D56A60D9-6F3E-4910-8EB0-88E8E85B2B64Q39135290-92E40413-74D7-47DF-BBC3-E4E921BECA77Q46296013-8546488E-628D-4410-80F0-C8C65F72C5FEQ49188547-8FA3793F-042E-486E-B142-03F57C6D52DBQ50134836-DA95B35F-C113-428C-88CA-D9DC83E9B363Q51157837-52C11477-0F10-4015-A0B5-25C68B632C47Q57022275-77C31385-7222-457A-8FC7-E69E72F77EEDQ58555302-A4A9EFF0-1C9A-4959-8B3F-CAC5A0E7FAF9Q58774746-A37F4C5F-B780-413C-B429-14F6B2E67910
P2860
XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
XPO1 Inhibition using Selinexo ...... oisomerase IIα to the Nucleus.
@en
XPO1 Inhibition using Selinexo ...... oisomerase IIα to the Nucleus.
@nl
type
label
XPO1 Inhibition using Selinexo ...... oisomerase IIα to the Nucleus.
@en
XPO1 Inhibition using Selinexo ...... oisomerase IIα to the Nucleus.
@nl
prefLabel
XPO1 Inhibition using Selinexo ...... oisomerase IIα to the Nucleus.
@en
XPO1 Inhibition using Selinexo ...... oisomerase IIα to the Nucleus.
@nl
P2093
P2860
P1476
XPO1 Inhibition using Selinexo ...... poisomerase IIα to the Nucleus
@en
P2093
Adrienne M Dorrance
Betina McNeil
Bhavana Bhatnagar
Michael Kauffman
Parvathi Ranganathan
Ramiro Garzon
Sharon Shacham
Trinayan Kashyap
Tzung-Huei Lai
William Blum
P2860
P304
P356
10.1158/1078-0432.CCR-15-2885
P407
P577
2016-06-29T00:00:00Z